Skip to main content
. Author manuscript; available in PMC: 2023 Dec 3.
Published in final edited form as: Drug Resist Updat. 2022 Oct 20;65:100885. doi: 10.1016/j.drup.2022.100885

Table 2.

Comparison of the in vitro activity of two DHODH inhibitors, olorofim and ipflufenoquin against Aspergillus species determined according to the EUCAST E.Def 9.4 with a complete inhibition endpoint and by applying a partial (50%) growth inhibition endpoint.

Inhibition endpoint criteria and species (n) Olorofim MIC (mg/L)
Ipflufenoquin MIC (mg/L)
0.002 0.004 0.008 0.016 0.03 0.06 0.125 0.25 0.5 1 2 > 4 0.06 0.125 0.25 0.5 1 2 4 8 16 32 > 32
Visual complete inhibition
A. sydowii (2) 1 1 2
A. flavus SC (2) 1 1 1 1
A. terreus SC (2) 2 1 1
A. fumigatus SC* (5) 1 1 3 1** 1** 1 2
A. nidulans SC (2) 2 2
A. niger SC (2) 1 1 2
A. calidoustus (2) 2 2
Section Aspergillus# (4) 4 1 3
Spec. 50% inhibition
A. sydowii (2) 1 1 1 1
A. flavus SC (2) 1 1 2
A. terreus SC (2) 1 1 1 1
A. fumigatus SC * (5) 1 4 4 1
A. nidulans SC (2) 2 1 1
A. niger SC (2) 1 1 2
A. calidoustus (2) 1 1 1 1
Section Aspergillus# (4) 4 1## 3
#

One A. montevidensis, one A. chevalieri, two A. intermedius.

##

one A. chevalieri.

*

Two A. fumigatus Cyp51A wild-type, one A. fumigatus Cyp51A TR34/L98H, and two A. hiratsukae.

**

Two A. hiratsukae.